Creating a decision aid tool for women with small, asymptomatic uterine leiomyomas
Official title: Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
Run by Shenzhen Maternity & Child Healthcare Hospital · NCT05500118 · Data updated 2026-11-12
This study is trying to create a helpful tool for women with small, non-problematic uterine fibroids to make better decisions about their health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Shenzhen Maternity & Child Healthcare Hospital Academic / other |
| Locations | 1 site (Shenzhen, Guangdong) |
| Status | Recruiting |
| Started | August 31, 2022 |
| Main results expected | August 31, 2024 |
| Study ends | August 31, 2027 |
| Registry record updated | August 12, 2022 |
| Trial ID | NCT05500118 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18-55 with asymptomatic small leiomyomas diagnosed via imaging.
✕Probably not a fit
Patients with symptomatic leiomyomas, those who have undergone myomectomy, or have other significant gynecological conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop a decision aid tool for women diagnosed with asymptomatic small leiomyomas, focusing on improving clinical decision-making. A committee of designers, doctors, nurses, and patients will collaborate to identify factors influencing these decisions based on clinical guidelines and evidence-based medicine. The study will involve prospective trials to assess whether the decision aid tool enhances patients' decision-making efficacy and improves their reported outcomes. Participants will be women aged 18-55 with specific criteria regarding their leiomyoma diagnosis.
Why it matters
Potential benefit: If successful, this tool could empower patients to make more informed decisions regarding their treatment options for asymptomatic leiomyomas.
How similar studies have gone: While similar decision aid tools have been explored in other contexts, this specific approach for asymptomatic leiomyomas is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of leiomyoma: patients with leiomyoma diagnosed by imaging examinations (ultrasound and MRI) have no clinical symptoms; 2. Female with age in 18-55 years old; 3. The maximum diameter of a single leiomyoma is less than 5m, and the number does not exceed 10 by MRI; 4. No contraindications for sedation and analgesia; 5. Patients and their families agree to join this study, and can follow up on time. Exclusion Criteria: 1. History of myomectomy, including transabdominal, laparoscopic, hysteroscopy, etc.; 2. History of connective tissue diseases or radiotherapy, especially abdominal radiotherapy; 3. With pregnancy, acute inflammation of the reproductive tract, or other gynecological benign and malignant diseases such as endometriosis and ovarian tumors; 4. The maximum diameter of leiomyoma is greater than or equal to 5cm; 5. Suspected malignant tumor, such as sarcoma; 6. Those with language communication barriers and unable to cooperate with sedative and analgesic programs; 7. Abdominal scarring, when diagnosed by ultrasound transabdominal scan, has obvious sound attenuation (more than 10mm range).
Where it's running
-
Shenzhen Maternal and Child Health Hospital
Shenzhen, Guangdong, China Recruiting
Study contacts
- Study coordinator: Yu Dai, Associate Professor
- Email: daiyu829@163.com
- Phone: 13828718985
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep muscle relaxation and a low-residue diet to improve the surgical view during vNOTES hysterectomy
This trial tests whether a preoperative low-residue diet and deeper muscle relaxation help doctors see better during a vaginally performed hysterectomy for benign conditions.
-
Letrozole treatment for uterine fibroids
This study tests if letrozole, a drug usually used for breast cancer, can help women with uterine fibroids feel better and improve their quality of life.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
EGCG and Vitamin D3 to Help Prevent Fibroid Recurrence After Fibroid Removal
This trial tests whether daily EGCG and vitamin D3 after fibroid surgery can reduce the chances of fibroids coming back in premenopausal women.
-
Electrical acupoint stimulation plus three anti-nausea drugs to prevent post-op nausea in high-risk women
This trial will test whether adding wearable electrical acupoint stimulation to three anti-nausea drugs reduces postoperative nausea and vomiting in high-risk adult women having elective laparoscopic surgery.
-
AI into Ultrasound Diagnostics in Reproductive Medicine
Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.